Healthcare Equipment and Supplies
Company Overview of Cognoptix, Inc.
Cognoptix, Inc. creates and develops a non-invasive eye scanning test for the early detection and diagnosis of Alzheimer’s disease. The company’s eye scanning test enables non-invasive quantitative measurements of amyloid aggregates in the eye to examine and measure deposits in specific areas of the lens as a means of early detection of Alzheimer’s disease. It also develops combined optical scanning devices and diagnostic agents for clinical, commercial, and academic research use. Cognoptix, Inc. was formerly known as Neuroptix Corporation and changed its name to Cognoptix, Inc. in October 2012. The company was founded in 2001 and is based in Concord, Massachusetts.
100 Main Street
Concord, MA 01720
Founded in 2001
Key Executives for Cognoptix, Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Cognoptix, Inc., please visit www.cognoptix.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.